Bio-Pharmaceutical Sciences: BioTherapeutics
BioTherapeutics is a specialisation of the Master’s programme Bio-Pharmaceutical Sciences of Leiden University. It offers research-orientated education on the areas of specific drug delivery techniques, and the development of new therapeutic approaches to treat immune-based disorders, such as atherosclerosis, metabolic disorders and inflammatory skin diseases. Research Project 1 will be conducted at the cluster BioTherapeutics of the LACDR on one of the research themes described below. Please check the tab “More info” for the general outline of the programme.
The mission of the Division of Drug Delivery Technology is to provide new strategies for the delivery of biologically active compounds at the right dose, at the right time and at the right place. Research activities are organized in two major, interrelated research lines: “Skin Research” and ”Biologics Research”. New research goes beyond conventional immunization, such as designing non-invasive delivery routes and microneedles.
The Division of Biopharmaceutics focusses on the development of experimental therapeutic approaches to treat cardiovascular disease and atherosclerosis. To study the complex interaction of drugs in different organic systems, research is performed at the gene, immune cell and lipid level in various in vitro and in vivo models; one of the strengths of the Division of Biopharmaceutics. Interventions developed so far range from bone marrow transplantation to experimental therapies using antibody-based interventions, therapeutic vaccines, and gene therapeutic approaches.